Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for B8FH31

Entry ID Method Resolution Chain Position Source
AF-B8FH31-F1 Predicted AlphaFoldDB

No variants for B8FH31

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for B8FH31

No associated diseases with B8FH31

3 regional properties for B8FH31

Type Name Position InterPro Accession
conserved_site Fumarate lyase, conserved site 278 - 287 IPR020557
domain Fumarate lyase, N-terminal 9 - 303 IPR022761
domain Argininosuccinate lyase, C-terminal 366 - 434 IPR029419

Functions

Description
EC Number 4.3.2.1 Lyases acting on amides, amidines, etc
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

1 GO annotations of molecular function

Name Definition
argininosuccinate lyase activity Catalysis of the reaction: N-(L-arginino)succinate = fumarate + L-arginine.

1 GO annotations of biological process

Name Definition
arginine biosynthetic process via ornithine The chemical reactions and pathways resulting in the formation of arginine (2-amino-5-guanidinopentanoic acid) via the intermediate compound ornithine.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MAEHKPWDGR FAEKTDDMVE AFTSSIQVDK RLYAHDITGS IAHARTLAEA GVITSDEADA
70 80 90 100 110 120
MEKGLRQVKG EIEAGNFKYD DSLEDIHMHI ESRLTEILGP TAAKLHTGRS RNDQIALDNR
130 140 150 160 170 180
LYLRDETRRI IAMLHELRQA IVDSAQAHLD YFVPGYTHLQ RAQPVLLSHH LMAYYEMFTR
190 200 210 220 230 240
DSDRFTDALY RINVMPLGSA ALAGTTFPLD REYTASLLGF EGVTQNSMDA VSDRDFIMEF
250 260 270 280 290 300
LSDASICMVH LSRMSEELVL WSSSEFAFLN MPDAFATGSS IMPQKKNPDV PELVRGKTGR
310 320 330 340 350 360
VVGSLMAILT TMKSLPMAYN RDMQEDKPPL FDAVDTLKAC VAMFARMVPK LEFNRRNMFD
370 380 390 400 410 420
ASNQGFLNAT DMADYLVEKG VPFREAHGIV GRAVAYALDR GRELHEISLN DLRKFSDKLE
430 440 450 460
KDLYEALTVE HVVERRRTIG GTASVNVIAA IGRAQTQLQA ETSGD